Literature DB >> 14676312

Mass-based fraction collection of crude synthetic peptides in analytical and preparative scale.

Ralf Moritz1, Nicola O'Reilly.   

Abstract

Synthetic peptides become more and more important as drug candidates in the treatment of a variety of diseases. A particular therapeutic focus for synthetic peptides is cancer treatment.1,2 In order to keep pace with the growing number of newly synthesized peptides, peptide purification should not represent the bottleneck in the drug discovery process. Since the target masses of synthetic peptides are well known, mass-based fraction collection represents an efficient technique for their purification. In contrast to fraction triggering with less specific detectors, employing a mass selective detector leads in each run only to the purification of the target mass. Consequently, it is not necessary to pick the compound of interest out of a series of redundant fractions. In this article we demonstrate mass-based purification of a variety of crude synthetic peptides by reversed phase high-performance liquid chromatography. The peptides were in the mass range from less than 1 kDa to more than 10 kDa and covered a pI range from 4 to 13. We particularly focused on some technical aspects of the system that were prerequisite for reliable compound purification with high recoveries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14676312      PMCID: PMC2279901     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  7 in total

1.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

Authors:  A A Davies; J Y Masson; M J McIlwraith; A Z Stasiak; A Stasiak; A R Venkitaraman; S C West
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 2.  Large-scale synthesis of peptides.

Authors:  L Andersson; L Blomberg; M Flegel; L Lepsa; B Nilsson; M Verlander
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 3.  Challenges for protein chemical synthesis in the 21st century: bridging genomics and proteomics.

Authors:  L P Miranda; P F Alewood
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

4.  CL22 - a novel cationic peptide for efficient transfection of mammalian cells.

Authors:  A M Haines; A S Irvine; A Mountain; J Charlesworth; N A Farrow; R D Husain; H Hyde; H Ketteringham; R H McDermott; A F Mulcahy; T L Mustoe; S C Reid; M Rouquette; J C Shaw; D R Thatcher; J H Welsh; D E Williams; W Zauner; R O Phillips
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

5.  Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers.

Authors:  F Hillenkamp; M Karas; R C Beavis; B T Chait
Journal:  Anal Chem       Date:  1991-12-15       Impact factor: 6.986

6.  Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides.

Authors:  J Rivier; R McClintock; R Galyean; H Anderson
Journal:  J Chromatogr       Date:  1984-04-24

7.  Effect of the mobile phase composition on the separation and detection of intact proteins by reversed-phase liquid chromatography-electrospray mass spectrometry.

Authors:  M C García; A C Hogenboom; H Zappey; H Irth
Journal:  J Chromatogr A       Date:  2002-05-31       Impact factor: 4.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.